Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Ming Hu

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Journal for Immunotherapy of Cancer|December 20, 2018
Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1Zhi-Fa Wen, Hongxiang Liu, Rong Gao, et al.
Human Gene Therapy|July 30, 2003
Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological resultsAnnemieke Dols, John W Smith, Sybren L Meijer, et al.
Journal for Immunotherapy of Cancer|December 21, 2017
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancerRachel E Sanborn, Helen J Ross, Sandra Aung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2018
Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor BWilliam van der Touw, Kyeongah Kang, Yi Luan, et al.
Journal for Immunotherapy of Cancer|July 14, 2019
Tumor-released autophagosomes induces CD4<sup>+</sup> T cell-mediated immunosuppression via a TLR2-IL-6 cascadeYong-Qiang Chen, Peng-Cheng Li, Ning Pan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responsesJohn W Smith, Edwin B Walker, Bernard A Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2025
IND-Enabling Studies for a TCR-T targeting a pancreatic cancer G12V KRAS mutationSizhen Wang, Guangjie Yu, Yanzhenzi Dai, et al.
The Journal of Clinical Investigation|October 24, 2018
Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunityHui-Ming Chen, William van der Touw, Yuan Shuo Wang, et al.
Seminars in Oncology|November 16, 2010
Signaling through OX40 enhances antitumor immunityShawn M Jensen, Levi D Maston, Michael J Gough, et al.
Current Molecular Medicine|August 20, 2009
Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effectsUlf Petrausch, Christian H Poehlein, Shawn M Jensen, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Journal for Immunotherapy of Cancer|December 20, 2018
Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1Zhi-Fa Wen, Hongxiang Liu, Rong Gao, et al.
Human Gene Therapy|July 30, 2003
Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological resultsAnnemieke Dols, John W Smith, Sybren L Meijer, et al.
Journal for Immunotherapy of Cancer|December 21, 2017
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancerRachel E Sanborn, Helen J Ross, Sandra Aung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2018
Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor BWilliam van der Touw, Kyeongah Kang, Yi Luan, et al.
Journal for Immunotherapy of Cancer|July 14, 2019
Tumor-released autophagosomes induces CD4<sup>+</sup> T cell-mediated immunosuppression via a TLR2-IL-6 cascadeYong-Qiang Chen, Peng-Cheng Li, Ning Pan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responsesJohn W Smith, Edwin B Walker, Bernard A Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2025
IND-Enabling Studies for a TCR-T targeting a pancreatic cancer G12V KRAS mutationSizhen Wang, Guangjie Yu, Yanzhenzi Dai, et al.
The Journal of Clinical Investigation|October 24, 2018
Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunityHui-Ming Chen, William van der Touw, Yuan Shuo Wang, et al.
Seminars in Oncology|November 16, 2010
Signaling through OX40 enhances antitumor immunityShawn M Jensen, Levi D Maston, Michael J Gough, et al.
Current Molecular Medicine|August 20, 2009
Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effectsUlf Petrausch, Christian H Poehlein, Shawn M Jensen, et al.
Pageof 8